AdventHealth Global Robotics Institute

01/05/2026

We're humbled to share that ABC News recognized a groundbreaking remote robotic surgery led by Dr. Vipul Patel at AdventHealth Celebration as one of the top medical breakthroughs of 2025. This innovation is helping bring specialized care closer to patients and families around the world no matter the distance.

Learn more:

ABC News has named a groundbreaking remote robotic surgery led by Dr. Vipul Patel, medical director of the Global Robotics Institute at AdventHealth Celebration, one of the top medical breakthroughs of 2025.

12/31/2025

https://abcnews.go.com/Health/groundbreaking-robotic-surgery-alzheimers-blood-test-7-biggest/story?id=128654798

From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a year full of medical breakthroughs.

12/17/2025

The Team That Made It All Possible 20k and Beyond

12/08/2025

Both Dr. Patel and Dr. Moschovas were recognized at the Translational Research Institute for the most publications this year

12/05/2025

We are grateful for this recognition from
It's an honor to receive the award for Most Publications in 2025, especially in a year where we pushed so hard on innovation, telesurgery, and collaborative research.
This achievement is a reflection of teamwork. None of our work happens alone.
I want to thank our entire GRI Research Department, our clinical and surgical teams, our fellows and students, and all the national and international centers that partnered with us in the multicentric studies we published this year.
Looking forward to continuing this work in 2026 as we keep advancing robotic surgery, digital surgery, and global telesurgery.

12/04/2025

Big congratulations on Dr. Patel's well-earned award at the 2025 AdventHealth Med Staff Excellence Awards Dinner.

11/17/2025

National Influence Award Winner 2025 - Dr. Vipul Patel

11/12/2025

An airman's courage and a surgeon's calling align in life-changing moment

11/11/2025

This morning Dr. Vipul Patel and his team completed their 20,000th robotic prostatectomy! Congratulations, what an accomplishment!

10/24/2025

Today Dr. Patel was invited to show his robotic techniques to WRSE12.

10/23/2025

This year, the NCCN updated its very high-risk criteria to include patients with at least two of the following: PSA > 40, cT3a–b, or Grade Group 4–5. About 35% of very high-risk patients show PSA persistence, indicating a potential need for adjuvant therapy.

Gleason 5+5 shows worse outcomes than 4+5 or 5+4, which may aid in biopsy interpretation.